Bone marrow scintigraphy using Technetium-99m antigranulocyte antibody in malignant lymphomas

Annals of Oncology

Volumn 10, Issue 1, 1999, Pages 79-85

  Krause, Thomas M ^b   Eisenmann, N ^c   Reinhardt, M ^c   Bathmann, J ^c   Altehoefer, C ^c   Finke, J ^a   Moser, E ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Abteilung Nuklearmedizin   (Germany)

^c NONE

Author keywords

Bone marrow scintigraphy; Immunoscintigraphy; Malignant lymphoma; Tc 99m labelled anti NCA 95

Indexed keywords

GRANULOCYTE ANTIBODY; TECHNETIUM 99M;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; BONE MARROW SCINTISCANNING; CANCER DIAGNOSIS; CANCER INFILTRATION; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; IMMUNOSCINTIGRAPHY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0033041115     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008356910239     Document Type: Article

References (28)

1. Hoane BR, Shields AF, Porter BA et al. Detection of lymphomatous bone marrow involvement with magnetic resonance imaging. Blood 1991; 78: 728-38.
2. Altehoefer C, Blum U, Bathmann J et al. Comparative diagnostic accuracy of magnetic resonance imaging and immunoscintigraphy for detection of bone marrow involvement in patients with malignant lymphoma. J Clin Oncol 1997; 15: 1754-60.
3. Buchegger F, Schreyer M, Carrel S et al. Monoclonal antibodies identify a CEA crossreacting antigen of 95 kD (NCA-95) distinct in the antigenicity and tissue distribution from the previously described NCA of 55 kD. Int J Cancer 1984; 33: 643-49.
4. Bosslet K, Lüben G, Schwarz A et al. Immunhistochemical localisation and molecular characteristics of three monoclonal antibody-defined epitopes detectable on carcinoembrionic antigen (CEA). Int J Cancer 1985; 36: 75-84.
5. Joseph K, Höffken H, Bosslet K et al. In vivo labelling of granulocytes with Tc-99m anti-NCA monoclonal antibodies for imaging inflammation. Eur J Nucl Med 1988; 14: 367-73.
6. Steinsträsser A, Schorlemmer HU, Schwarz A et al. A novel Tc-99m labelled antibody for in vivo targeting of granulocytes. J Nucl Med 1988; 29: 925 (Abstr).
7. Reske SN, Karstens JH, Glöckner W et al. Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma. Lancet 1989; i: 299-301.
8. Chung JK, Yeo J, Lee DS et al. Bone marrow scintigraphy using technetium-99m-antigranulocyte antibody in hematologic disorders. J Nucl Med 1996; 37: 978-82
9. Dunker CM, Carrió I, Berná L et al. Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer. J Nucl Med 1990; 31: 1450-5.
10. Munz DL, Sandrock D, Rillinger N. Comparison of immunoscintigraphy and colloid scintigraphy of hone marrow. Lancet 1990; ii: 258 (Letter).
11. Reske SN, Karstens JH, Henrich MM et al. Detection of skeletal involvement in malignant disease by immunoscintigraphy of bone marrow. Nuklearmedizin 1993; 32: 111-9.
12. Stansteld, AG, Diebold J, Noel H et al. Updated Kiel Classification for lymphomas. Lancet 1988; i: 192-393 (Letter).
13. Lennert K, Stein H. Personal points of view on the Kiel Classification. Recent Results Cancer Res 1978; 64: 31-7.
14. Carbone PP, Kaplan HS, Musshoff K et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860-1.
15. Dawson-Saunders B, Trapp RG. Basic & Clinical Biostatistics. Norwalk: Appleton & Lange 1994.
16. Webb DI, Ubogy G, Silver RT. Importance of bone marrow biopsy in the clinical staging of Hodgkin's disease. Cancer 1970; 26: 311-7.
17. Bartl R, Frisch B, Burkhardt R et al. Assessment of bone marrow histology in Hodgkin's disease: Correlation with clinical factors. Br J Haematol 1982; 51: 345-60.
18. Bartl R, Frisch B, Burkhardt R et al. Lymphoproliferations in bone marrow: Identification and evolution, classification and staging. J Clin Pathol 1984; 37: 233-54
19. Dick F, Bloomfield CD, Brunning RD. Incidence, cytology, and histopathology of non-Hodgkin's lymphomas in the bone marrow. Cancer 1974 33: 1382-98.
20. Burkhardt R. Bone marrow biopsy in malignant lymphoma. Verh Dtsch Ges Path 1983; 67: 522-47.
21. Brunning RD, Bloomfield CD, McKenna RW et al. Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann Intern Med 1975; 82: 365-6.
22. Widding A, Smolorz J, Franke M et al. Bone marrow investigation with technetium-99m microcolloid and magnetic resonance imaging in patients with malignant myelolympho-proliferative diseases. Eur Nucl Med 1989; 15: 230-8.
23. Linden A, Zankovich R, Theissen P et al. Malignant lymphoma. Bone marrow imaging versus biopsy. Radiology 1989; 173: 335-9.
24. Coller BS, Chabner BA, Gralnick HR. Frequencies and patterns of bone marrow involvement in non-Hodgkin's lymphomas: Observations on the value of bilateral biopsies. Am J Hematol 1977; 3: 105-19.
25. Linden A, Zankovich R, Theissen P et al. Bone marrow scintigraphy and MR tomography in malignant lymphoma: Comparison with results of histology. Nuklearmedizin 1989; 28: 166-71.
26. Reske SN. Recent advances in bone marrow scanning. Eur J Nucl Med 1991; 18: 203-21.
27. Steinsträsser A, Oberhausen E. Granulocyte Labelling Kit BW 250/183. Result of the European multicenter trial. Nuklearmedizin 1996; 25: 1-11.
28. Hertel A, Baum RP, Auerbach B et al. Clinical relevance of human anti-mouse antibodies (HAMA) in immunoscintigraphy. Nuklearmedizin 1990; 29: 221-7.